NCT02183480View on ClinicalTrials.gov

Dose Proportionality of Different Dose Strengths of Linagliptin Tablets After Oral Administration to Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

September 30, 2009

Conditions
Healthy
Interventions
DRUG

Linagliptin, low dose

DRUG

Linagliptin, medium dose

DRUG

Linagliptin, high dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02183480 - Dose Proportionality of Different Dose Strengths of Linagliptin Tablets After Oral Administration to Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter